NF-κB inhibition was one of the main downstream effects of TREK-1 blockage, IL-4 administration, NLRC5 deficiency, and CTRP3 overexpression, and it was associated with reduced depression-like behaviors in UCMS mice [61,62,63,64]. The gene discussed is IL4; the disease is depressive symptom measurement.